C. Magnusson, J. Baron, N. Correia, R. Bergström, H. Adami et al., Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy, International Journal of Cancer, vol.4, issue.3, pp.339-383, 1999.
DOI : 10.1002/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.0.CO;2-6

I. Persson, E. Weiderpass, L. Bergkvist, R. Bergström, and C. Schairer, Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement, Cancer Causes and Control, vol.10, issue.4, pp.253-60, 1999.
DOI : 10.1023/A:1008909128110

C. Li, N. Weiss, J. Stanford, and J. Daling, Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women, Cancer, vol.128, issue.11, pp.2570-2577, 2000.
DOI : 10.1002/1097-0142(20000601)88:11<2570::AID-CNCR20>3.0.CO;2-O

P. Moorman, H. Kuwabara, R. Millikan, and B. Newman, Menopausal hormones and breast cancer in a biracial population, Am J Public Health, vol.90, pp.966-71, 2000.

R. Ross, A. Paganini-hill, P. Wan, and M. Pike, Effect of Hormone Replacement Therapy on Breast Cancer Risk: Estrogen Versus Estrogen Plus Progestin, Journal of the National Cancer Institute, vol.92, issue.4, pp.328-360, 2000.
DOI : 10.1093/jnci/92.4.328

G. Ursin, C. Tseng, A. Paganini-hill, S. Enger, P. Wan et al., Does Menopausal Hormone Replacement Therapy Interact With Known Factors to Increase Risk of Breast Cancer?, Journal of Clinical Oncology, vol.20, issue.3, pp.699-706, 2002.
DOI : 10.1200/JCO.2002.20.3.699

C. Schairer, J. Lubin, R. Troisi, S. Sturgeon, L. Brinton et al., Menopausal Estrogen and Estrogen-Progestin Replacement Therapy and Breast Cancer Risk, JAMA, vol.283, issue.4, pp.485-91, 2000.
DOI : 10.1001/jama.283.4.485

C. Chen, N. Weiss, P. Newcomb, W. Barlow, and E. White, Hormone Replacement Therapy in Relation to Breast Cancer, JAMA, vol.287, issue.6, pp.734-775, 2002.
DOI : 10.1001/jama.287.6.734

J. Daling, K. Malone, D. Doody, L. Voigt, L. Bernstein et al., Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma, Cancer, vol.73, issue.12, pp.2455-64, 2002.
DOI : 10.1002/cncr.10984

L. Weiss, R. Burkman, K. Cushing-haugen, L. Voigt, M. Simon et al., Hormone Replacement Therapy Regimens and Breast Cancer Risk, Obstetrics & Gynecology, vol.100, issue.6, pp.1148-58, 2002.
DOI : 10.1097/00006250-200212000-00003

V. Kirsh and N. Kreiger, Estrogen and estrogen-progestin replacement therapy and risk of postmenopausal breast cancer in Canada, Cancer Causes and Control, vol.13, issue.6, pp.583-90, 2002.
DOI : 10.1023/A:1016330024268

R. Li, F. Gilliland, K. Baumgartner, and J. Samet, Hormone replacement therapy and breast carcinoma risk in Hispanic and non-Hispanic women, Cancer, vol.85, issue.5, pp.960-968, 2002.
DOI : 10.1002/cncr.10791

P. Newcomb, L. Titus-ernstoff, K. Egan, A. Trentham-dietz, J. Baron et al., Postmenopausal estrogen and progestin use in relation to breast cancer risk, Cancer Epidemiol Biomarkers Prev, vol.11, pp.593-600, 2002.

V. Beral, E. Banks, and G. Reeves, Evidence from randomised trials on the long-term effects of hormone replacement therapy, The Lancet, vol.360, issue.9337, pp.942-946, 2002.
DOI : 10.1016/S0140-6736(02)11032-4